379 related articles for article (PubMed ID: 34235215)
21. Incidence of primary cutaneous T-cell lymphoma in Norway.
Saunes M; Nilsen TI; Johannesen TB
Br J Dermatol; 2009 Feb; 160(2):376-9. PubMed ID: 18808419
[TBL] [Abstract][Full Text] [Related]
22. Mycosis fungoides and Sézary syndrome in Japan. Clinicopathologic study of 107 autopsy cases.
Arai E; Katayama I; Ishihara K
Pathol Res Pract; 1991 May; 187(4):451-7. PubMed ID: 1876527
[TBL] [Abstract][Full Text] [Related]
23. Cutaneous lymphomas other than mycosis fungoides in Singapore: a clinicopathological analysis using recent classification systems.
Tan SH; Sim CS; Ong BH
Br J Dermatol; 2003 Sep; 149(3):542-53. PubMed ID: 14510987
[TBL] [Abstract][Full Text] [Related]
24. Primary cutaneous lymphomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
Willemze R; Hodak E; Zinzani PL; Specht L; Ladetto M;
Ann Oncol; 2013 Oct; 24 Suppl 6():vi149-54. PubMed ID: 23868906
[No Abstract] [Full Text] [Related]
25. Primary cutaneous lymphomas: the analysis of cases treated in the Department of Dermatology University Hospital in Krakow.
Spałkowska M; Brzewski P; Walter S; Jaworek AK; Sułowicz J; Andres M; Wojas-Pelc A
Przegl Lek; 2016; 73(7):452-9. PubMed ID: 29676886
[TBL] [Abstract][Full Text] [Related]
26. Survival and Prognostic Factors in Patients with Aggressive Cutaneous T-cell Lymphomas.
Franceschi J; Ehret M; Visseaux L; Durlach A; Barbe C; Durot É; Grange F
Acta Derm Venereol; 2022 Mar; 102():adv00676. PubMed ID: 35083494
[TBL] [Abstract][Full Text] [Related]
27. Clinicopathologic analysis of cutaneous lymphoma in taiwan: a high frequency of extranodal natural killer/t-cell lymphoma, nasal type, with an extremely poor prognosis.
Liao JB; Chuang SS; Chen HC; Tseng HH; Wang JS; Hsieh PP
Arch Pathol Lab Med; 2010 Jul; 134(7):996-1002. PubMed ID: 20586627
[TBL] [Abstract][Full Text] [Related]
28. Survival data for 299 patients with primary cutaneous lymphomas: a monocentre study.
Hallermann C; Niermann C; Fischer RJ; Schulze HJ
Acta Derm Venereol; 2011 Sep; 91(5):521-5. PubMed ID: 21547335
[TBL] [Abstract][Full Text] [Related]
29. Evaluation of Associated Lymphomas and Their Risk Factors in Patients with Lymphomatoid Papulosis: A Retrospective Single-Center Study from Turkey.
Baykal C; Kılıç Sayar S; Yazganoğlu KD; Büyükbabani N
Turk J Haematol; 2021 Feb; 38(1):49-56. PubMed ID: 33389922
[TBL] [Abstract][Full Text] [Related]
30. [Diagnosis and treatment for cutaneous T-cell lymphomas].
Hamada T; Iwatsuki K
Nihon Rinsho; 2012 Apr; 70 Suppl 2():537-43. PubMed ID: 23134012
[No Abstract] [Full Text] [Related]
31. Primary cutaneous peripheral T-cell lymphoma, not otherwise specified, associated with lymphomatoid papulosis after a 9-year follow up: A case report.
Muraoka K; Fujimoto M; Iwahashi Y; Matsuzaki I; Yonei N; Murata SI; Jinnin M
J Dermatol; 2020 Jun; 47(6):641-645. PubMed ID: 32323371
[TBL] [Abstract][Full Text] [Related]
32. Primary cutaneous T-cell lymphoma: experience from the Peruvian National Cancer Institute.
Ruiz R; Morante Z; Mantilla R; Mas L; Casanova L; Gomez HL
An Bras Dermatol; 2017; 92(5):649-654. PubMed ID: 29166501
[TBL] [Abstract][Full Text] [Related]
33. Clinicopathologic Features of Cutaneous T-Cell Lymphomas With Extracutaneous Metastasis: A Case Series.
Tang H; Matsumoto N; Foss F; Xu M; Ahmed A
Clin Lymphoma Myeloma Leuk; 2023 Nov; 23(11):e405-e410. PubMed ID: 37659965
[TBL] [Abstract][Full Text] [Related]
34. Comprehensive analysis of cutaneous T-cell lymphoma (CTCL) incidence and mortality in Canada reveals changing trends and geographic clustering for this malignancy.
Ghazawi FM; Netchiporouk E; Rahme E; Tsang M; Moreau L; Glassman S; Provost N; Gilbert M; Jean SE; Pehr K; Sasseville D; Litvinov IV
Cancer; 2017 Sep; 123(18):3550-3567. PubMed ID: 28493286
[TBL] [Abstract][Full Text] [Related]
35. Characteristics and outcomes of 727 patients with mycosis fungoides and Sézary syndrome from a Brazilian cohort.
Miyashiro D; Sanches JA
Int J Dermatol; 2022 Apr; 61(4):442-454. PubMed ID: 34435672
[TBL] [Abstract][Full Text] [Related]
36. Local radiation for cutaneous T-cell lymphoma other than mycosis fungoides and Sézary syndrome.
Shikama N
Chin Clin Oncol; 2019 Feb; 8(1):8. PubMed ID: 30180750
[TBL] [Abstract][Full Text] [Related]
37. Mycosis fungoides and Sézary syndrome: a population-wide study on prevalence and health care use in Finland in 1998-2016.
Keto J; Hahtola S; Linna M; Väkevä L
BMC Health Serv Res; 2021 Feb; 21(1):166. PubMed ID: 33618714
[TBL] [Abstract][Full Text] [Related]
38. Cutaneous T-cell lymphomas (including rare subtypes). Current concepts. II.
Paulli M; Berti E
Haematologica; 2004 Nov; 89(11):1372-88. PubMed ID: 15531460
[TBL] [Abstract][Full Text] [Related]
39. Care structure of patients with mycosis fungoides and Sézary syndrome in Germany - Care research based on SHI claims data.
Assaf C; Dobos G; Zech IM; Doess A; Hibbe T; Jadasz JJ
J Dtsch Dermatol Ges; 2022 May; 20(5):643-651. PubMed ID: 35499207
[TBL] [Abstract][Full Text] [Related]
40. CD30-Negative Cutaneous T-Cell Lymphomas Other than Mycosis Fungoides.
Willemze R
Surg Pathol Clin; 2014 Jun; 7(2):229-52. PubMed ID: 26837200
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
